| Literature DB >> 30042873 |
Mark Roe1, John C Murphy2, Conor Gissane3, Catherine Blake1.
Abstract
Managing injury risk requires an understanding of how and when athletes sustain certain injuries. Such information guides organisations in establishing evidence-based priorities and expectations for managing injury risk. In order to minimise the impact of sports injuries, attention should be directed towards injuries that occur frequently, induce substantial time-loss, and elevate future risk. Thus, the current study aimed to investigate the rate at which elite Gaelic football players sustain different time-loss injuries during match-play and training activities. Datasets (n = 38) from elite Gaelic football teams (n = 17) were received by the National Gaelic Athletic Association Injury Surveillance Database from 2008 to 2016. A total of 1,614 time-loss injuries were analysed. Each season teams sustained 24.0 (interquartile ranges) (IQR 16.0-32.0) and 15.0 (IQR 10.0-19.0) match-play and training injuries, respectively. When exposure was standardised to 1,000 h, greater rates of injury (12.9, 95% CI [11.7-14.3]) and time-loss days (13.4, 95% CI [12.3-14.9]) were sustained in match-play than in training. Acute injury rates were 3.1-times (95% CI [2.7-3.4]) greater than chronic/overuse injuries. Similarly, non-contact injury rates were 2.8-times (95% CI [2.5-3.2]) greater than contact injuries. A total of 71% of injuries in elite Gaelic football affected five lower limb sites. Four lower limb-related clinical entities accounted for 40% of all time-loss injuries (hamstring, 23%; ankle sprain, 7%; adductor-related, 6%; quadriceps strain, 5%). Thus, most risk management and rehabilitation strategies need to be centred around five lower limb sites-and just four clinical entities. Beyond these, it may be highly unlikely that reductions in injury susceptibility can be attributed to specific team interventions. Thus, compliance with national databases is necessary to monitor injury-related metrics and future endeavours to minimise injury risk.Entities:
Keywords: Clinical entities; Epidemiology; Gaelic football; Injury surveillance; Time-loss
Year: 2018 PMID: 30042873 PMCID: PMC6055676 DOI: 10.7717/peerj.4895
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Injury surveillance protocol.
Outline of stages involved to recruit and obtain injury-related data from team physiotherapists and medical doctors for the GAA National Injury Surveillance Database in 2008–2016.
Figure 2Data entry pathway for registering a time-loss injury.
Injury rates per team.
| Median | Interquartile range | |
|---|---|---|
| Total injuries | 42.0 | 31.0–53.0 |
| Match-play injuries | 24.0 | 16.0–32.0 |
| Training injuries | 15.0 | 10.0–19.0 |
| Lower limb | 33.0 | 24.0–45.0 |
| Upper limb | 4.0 | 3.0–7.0 |
| Trunk | 2.0 | 1.0–5.0 |
| Head/neck | 1.0 | 1.0–2.0 |
| Contact | 11.0 | 7.0–16.0 |
| Non-contact | 30.0 | 21.0–39.0 |
| Acute | 32.0 | 26.0–36.0 |
| Chronic/overuse | 9.0 | 5.0–13.0 |
| New | 31.0 | 23.0–43.0 |
| Recurrent | 9.0 | 7.0–11.0 |
| Mild | 11.0 | 6.0–17.0 |
| Moderate | 19.0 | 11.0–26.0 |
| Severe | 10.0 | 6.0–12.0 |
| Preseason | 4.0 | 2.0–7.0 |
| Competitive cycle 1 | 20.0 | 14.0–29.0 |
| Midseason | 7.0 | 4.0–9.0 |
| Competitive cycle 2 | 13.0 | 8.0–16.0 |
Note:
Presented as median (interquartile range) per season.
Five most commonly injured sites.
| All injuries | Match-play | Training | |
|---|---|---|---|
| 1 | Hamstring, 23.9% (21.9–26.0) | Hamstring, 23.1% (20.2–26.0) | Hamstring, 27.6% (24.2–31.2) |
| 2 | Groin, 14.9% (13.0–16.7) | Knee, 12.7% (10.5–15.0) | Groin, 17.5% (14.8–20.6) |
| 3 | Ankle, 11.7% (10.1–13.3) | Ankle, 12.2% (9.9–14.2) | Ankle, 10.7% (8.4–13.3) |
| 4 | Knee, 11.1% (9.5–12.6) | Groin, 10.8% (8.9–12.9) | Quadriceps, 10.1% (7.8–12.5) |
| 5A | Quadriceps, 9.3% (7.9–10.3) | Shoulder, 9.7% (7.9–11.7) | Knee, 8.6% (6.3–10.7) |
| 5B | – | Quadriceps, 9.7% (7.7–11.6) | – |
| Combined | 70.9% (62.4–78.9) | 78.2% (65.1–91.4) | 74.5% (61.5–88.3) |
Note:
Presented with corresponding 95% confidence intervals.
Most common clinical entities as per injury diagnosis.
| Team rate per season (median, IQR) | Percentage of all injuries | Prevalence | Incidence | Match-play incidence | Training incidence | Likelihood non-contact related | Likelihood occuring in match-play | Likelihood occuring in training | |
|---|---|---|---|---|---|---|---|---|---|
| All injuries | 42 (31–53) | – | 69.8% (67.4–72.3) | 9.2 (8.8–9.6) | 50.5 (47.2–53.8) | 3.9 (3.6–4.3) | 72.9% (70.7–75.1) | 55.8% (53.4–58.2) | 38.7% (36.3–41.2) |
| Hamstring: muscle/tendon strain | 9 (7–12) | 23.0% (21.0–24.9) | 19.7% (17.5–21.8) | 2.1 (1.9–2.3) | 11.0 (9.5–12.5) | 1.1 (0.9–1.2) | 98.1% (96.8–99.5) | 52.7% (48.1–57.7) | 45.2% (40.4–49.7) |
| Ankle: sprain | 3 (1–4) | 6.8% (5.6–7.9) | 7.4% (6.0–8.8) | 0.6 (0.5–0.7) | 3.8 (2.9–4.7) | 0.2 (0.2–0.3) | 80.2% (72.1–87.4) | 62.2% (53.2–71.2) | 32.4% (23.4–40.5) |
| Groin: adductor-related | 2 (1–4) | 5.9% (4.8–6.9) | 6.0% (4.7–7.2) | 0.5 (0.4–0.7) | 2.5 (1.8–3.3) | 0.3 (0.2–0.4) | 94.8% (89.6–99.0) | 47.9% (37.9–57.9) | 46.9% (36.9–56.9) |
| Quadriceps: muscle strain | 2 (1–4) | 5.2% (4.2–6.4) | 5.8% (4.5–7.1) | 0.5 (0.4–0.6) | 2.0 (1.3–2.6) | 0.3 (0.2–0.4) | 98.8% (96.5–100) | 41.2% (30.6–50.6) | 58.8% (49.4–69.4) |
| Calf: muscle/tendon strain | 1 (0–4) | 4.3% (3.4–5.3) | 4.5% (3.4–5.6) | 0.4 (0.3–0.5) | 2.0 (1.3–2.7) | 0.2 (0.1–0.3) | 94.4% (87.3–98.6) | 50.7% (38.0–62.0) | 47.9% (36.6–60.6) |
| Quadriceps: bruising/haematoma | 1 (0–3) | 3.9% (3.0–4.8) | 4.1% (3.1–5.2) | 0.4 (0.3–0.4) | 2.8 (2.1–3.6) | 0.1 (0.0–0.1) | 7.9% (1.6–15.9) | 81.0% (71.4–90.5) | 17.5% (7.9–27.0) |
| Groin: hip-related | 1 (0–3) | 2.7% (2.0–3.5) | 2.9% (2.0–3.9) | 0.3 (0.2–0.3) | 0.9 (0.5–1.3) | 0.1 (0.1–0.2) | 68.2% (54.5–81.8) | 35.6% (21.6–49.5) | 46.7% (32.1–61.2) |
| Shoulder AC joint sprain | 1 (0–2) | 2.4% (1.7–3.1) | 2.9% (2.0–3.8) | 0.2 (0.2–0.3) | 1.8 (1.2–2.5) | 0.04 (0.0–0.1) | 15.0% (5.0–27.4) | 82.5% (70.0–92.5) | 15.0% (5.0–27.5) |
| Ankle: general | 1 (0–2) | 2.4% (1.7–3.1) | 2.7% (1.8–3.6) | 0.2 (0.2–0.3) | 1.1 (0.6–1.6) | 0.1 (0.1–0.1) | 76.9% (64.1–89.7) | 51.3% (33.3–66.7) | 41.0% (25.6–56.4) |
| Groin: other | 1 (0–3) | 2.3% (1.6–3.1) | 2.6% (1.7–3.4) | 0.2 (0.2–0.3) | 0.7 (0.3–1.0) | 0.1 (0.1–0.2) | 89.5% (78.9–97.4) | 31.6% (16.8–46.4) | 47.4% (31.5–63.2) |
| Groin: lliopsoas-related | 1 (0–3) | 2.1% (1.5–2.9) | 2.5% (1.7–3.3) | 0.2 (0.1–0.3) | 0.8 (0.4–1.3) | 0.1 (0.1–0.2) | 88.6% (77.1–97.1) | 42.9% (26.5–59.3) | 48.6% (32.0–65.1) |
| Knee: patellar tendinopathy | 0 (0–1) | 2.1% (1.4–2.8) | 2.3% (1.5–3.1) | 0.2 (0.1–0.3) | 1.3 (0.8–1.8) | 0.03 (0.0–0.1) | 97.1% (91.2–100) | 67.6% (52.9–82.4) | 11.8% (2.9–23.5) |
| Shoulder: general | 0 (0–1) | 1.7% (1.2–2.3) | 2.1% (1.3–2.9) | 0.2 (0.1–0.2) | 1.0 (0.5–1.5) | 0.06 (0.0–0.1) | 25.0% (7.1–42.9) | 64.3% (46.4–82.1) | 35.7 (17.9–53.6) |
| Knee: MCL sprain | 1 (0–2) | 1.6% (1.0–2.3) | 1.7% (1.0–2.4) | 0.2 (0.1–0.2) | 1.2 (0.7–1.7) | 0.03 (0.0–0.1) | 42.3% (23.1–61.5) | 80.8% (65.4–96.2) | 15.4% (3.8–30.8) |
| Knee: general | 0 (0–1) | 1.6% (1.0–2.2) | 2.0% (1.2–2.7) | 0.2 (0.1–0.2) | 0.6 (0.3–1.0) | 0.1 (0.0–0.1) | 61.5% (42.4–80.8) | 42.3% (23.1–61.5) | 53.8% (34.6–73.1) |
| Back: disc pathology | 0 (0–1) | 1.5% (1.0–2.1) | 1.7% (1.0–2.3) | 0.2 (0.1–0.2) | 0.4 (0.1–0.8) | 0.1 (0.0–0.1) | 96.0% (88.0–100) | 32.0% (16.0–52.0) | 44.0% (24.0–64.0) |
| Knee: bruising/haematoma | 0 (0–1) | 1.5% (0.9–2.2) | 2.5% (1.7–3.3) | 0.2 (0.1–0.3) | 1.3 (0.8–1.8) | 0.06 (0.0–0.1) | 37.1% (22.9–54.3) | 65.7% (48.6–82.8) | 25.7% (11.4–40.0) |
Consequences of the most common clinical entities.
| Mean time-loss | Injury burden | Percentage of unavailability | Likelihood of recurrence | |
|---|---|---|---|---|
| All injuries | 25.9 (23.5–28.4) | 238.3 (206.8–272.6) | – | 71.8% (63.5–80.2) |
| Hamstring: muscle/tendon strain | 25.2 (20.5–31.0) | 52.9 (39.0–71.3) | 22.2% (18.8–26.2) | 44.1% (38.0–50.1) |
| Ankle: sprain | 24.5 (18.1–32.9) | 14.7 (9.1–23.0) | 6.2% (4.4–8.4) | 13.3% (6.5–20.0) |
| Groin: adductor-related | 25.3 (15.9–37.1) | 12.7 (6.4–26.0) | 5.3% (3.1–9.5) | 21.5% (12.5–30.6) |
| Quadriceps: muscle strain | 24.7 (15.5–38.9) | 12.4 (6.2–23.3) | 5.2% (3.0–8.6) | 10.4% (3.6–17.2) |
| Calf: muscle/tendon strain | 29.2 (19.2–42.3) | 11.7 (5.8–21.2) | 4.9% (2.8–7.8) | 18.3% (8.5–28.1) |
| Quadriceps: bruising/haematoma | 9.7 (7.8–11.9) | 3.9 (2.3–4.8) | 1.6% (1.1–1.7) | 14.5% (5.2–23.9) |
| Groin: hip-related | 32.1 (19.0–47.3) | 9.6 (3.8–14.2) | 4.0% (1.8–5.2) | 12.8% (2.3–23.3) |
| Shoulder AC joint sprain | 34.2 (20.0–54.0) | 6.8 (4.0–16.2) | 2.9% (1.9–5.9) | 5.3% (1.8–12.4) |
| Ankle: general | 26.8 (17.7–38.3) | 5.4 (3.5–11.5) | 2.2% (1.7–4.2) | 8.3% (0.7–17.4) |
| Groin: other | 18.1 (9.7–29.1) | 3.6 (1.9–8.7) | 1.5% (0.9–3.2) | 11.8% (0.9–22.6) |
| Groin: Iliopsoas-related | 13.3 (10.1–17.1) | 2.7 (1.0–5.1) | 1.1% (0.5–1.9) | 6.1% (2.1–14.2) |
| Knee: patellar tendinopathy | 41.7 (22.7–64.3) | 8.3 (2.3–19.3) | 3.5% (1.1–7.1) | 20.0% (5.7–34.3) |
| Shoulder: general | 15.8 (10.9–20.8) | 3.2 (1.1–4.2) | 1.3% (0.5–1.5) | None registered |
| Knee: MCL sprain | 32.2 (22.0–43.4) | 6.4 (2.2–8.7) | 2.7% (1.1–3.2) | 13.0% (0.7–26.8) |
| Knee: general | 19.5 (12.1–27.3) | 3.9 (1.2–5.5) | 1.6% (0.6–2.0) | None registered |
| Back: disc pathology | 41.9 (12.9–85.1) | 8.4 (1.3–17.0) | 3.5% (0.6–6.2) | 13.6% (0.7–28.0) |
| Knee: bruising/haematoma | 18.8 (10.7–31.3) | 3.8 (1.1–6.3) | 1.6% (0.5–3.4) | 6.1% (2.1–14.2) |
Note:
Likelihood of recurrence statistic in row ‘All Injuries’ refers to proportion of players sustaining a subsequent injury following a return to sport.
Frequency and nature of match-play and training injuries per 1,000 h.
| Incidence | Non-contact | Contact | NC: C IRR | Acute | Chronic/overuse | A: C/O IRR | |
|---|---|---|---|---|---|---|---|
| All regions | 49.8 (46.5–53.0) | 29.1 (26.6–31.6) | 21.0 (18.6–22.8) | 1.41 (1.23–1.60) | 41.9 (38.9–38.9) | 7.8 (6.5–9.1) | 5.35 (4.48–6.39) |
| Lower limb | 38.7 (35.8–41.6) | 25.5 (23.2–27.9) | 13.2 (11.5–14.9) | 1.94 (1.66–2.26) | 31.7 (29.1–34.3) | 7.0 (5.8–8.2) | 4.52 (3.74–5.48) |
| Upper limb | 7.1 (5.8–8.3) | 2.4 (1.7–3.1) | 4.7 (3.7–5.7) | 0.51 (0.3–0.74) | 6.6 (5.4–7.7) | 0.5 (0.2–0.8) | 13.11 (6.66–25.81) |
| Trunk | 2.5 (1.7–3.2) | 1.2 (0.7–1.7) | 1.3 (0.8–1.8) | 0.91 (0.51–1.65) | 2.1 (1.4–2.8) | 0.3 (0.1–0.6) | 6.33 (2.68–14.98) |
| Head/neck | 1.6 (1.0–2.1) | – | 1.6 (1.0–2.1) | – | 1.6 (1.0–2.1) | – | – |
| All regions | 3.9 (3.5–4.2) | 2.7 (2.4–3.0) | 1.2 (1.0–1.3) | 2.34 (1.97–2.78) | 2.9 (2.7–3.2) | 0.9 (0.8–1.1) | 3.24 (2.69–3.90) |
| Lower limb | 3.2 (2.9–3.5) | 2.4 (2.2–2.7) | 0.8 (0.7–0.9) | 3.02 (2.48–3.69) | 2.4 (2.2–2.7) | 0.8 (0.7–1.0) | 2.99 (2.45–3.65) |
| Upper limb | 0.2 (0.2–0.3) | 0.1 (0.0–0.1) | 0.2 (0.1–0.2) | 0.44 (0.23–0.88) | 0.2 (0.2–0.3) | 0.02 (0.00–0.04) | 12.00 (3.70–38.97) |
| Trunk | 0.3 (0.2–0.4) | 0.2 (0.1–0.2) | 0.1 (0.1–0.2) | 1.71 (0.94–3.10) | 0.2 (0.1–0.3) | 0.1 (0.0–0.1) | 2.54 (1.34–4.82) |
| Head/neck | 0.1 (0.1–0.1) | 0.02 (0.00–0.04) | 0.1 (0.0–0.1) | 0.25 (0.07–0.89) | 0.1 (0.1–0.1) | – | – |
Note:
IRR, Incidence rate ratio.
Injuries per 1,000 h in match-play compared to training.
| IRR | Non-contact | Contact | Acute | Chronic/overuse | Mild | Moderate | Severe | |
|---|---|---|---|---|---|---|---|---|
| All regions | 12.93 (11.69–14.32) | 10.78 (9.50–12.24) | 17.97 (15.07–21.43) | 14.26 (12.72–15.98) | 8.64 (6.86–10.89) | 10.94 (9.00–13.29) | 13.26 (11.48–15.31) | 15.98 (12.78–19.99) |
| Lower limb | 12.01 (10.73–13.45) | 10.54 (9.22–12.06) | 16.46 (13.28–20.39) | 13.12 (11.54–14.92) | 8.68 (6.79–11.09) | 10.50 (8.44–13.05) | 11.78 (1.07–13.79) | 14.90 (11.58–19.18) |
| Upper limb | 28.94 (20.22–41.42) | 31.85 (16.80–60.38) | 27.65 (17.93–42.65) | 29.13 (20.06–42.29) | 26.66 (7.22–98.46) | 33.01 (14.33–76.04) | 23.96 (14.85–38.65) | 61.22 (30.43–123.16) |
| Trunk | 8.50 (5.62–12.85) | 6.44 (3.67–11.28) | 12.02 (6.43–22.50) | 10.23 (6.42–16.31) | 4.10 (1.56–10.79) | 5.43 (2.57–11.50) | 19.39 (9.50–39.50) | 8.00 (3.25–19.68) |
| Head/neck | 16.59 (8.86–31.05) | – | 20.74 (10.55–40.77) | 16.59 (8.86–31.05) | – | 12.22 (4.92–30.38) | 41.47 (11.92–144.31) | 11.85 (2.65–52.94) |
Note:
IRR, Incidence rate ratio.
Time-loss per activity.
| Mild | Moderate | Severe | Mild incidence | Moderate incidence | Severe incidence | |
|---|---|---|---|---|---|---|
| All injuries | 27.0% (24.4–29.5) | 49.8% (47.0–53.0) | 23.2% (20.6–25.7) | 2.5 (2.2–2.7) | 4.5 (4.2–4.8) | 2.1 (1.9–2.3) |
| Lower limb | 26.6% (23.4–29.5) | 50.8% (47.4–54.2) | 22.6% (19.9–25.6) | 1.9 (1.7–2.1) | 3.7 (3.4–4.0) | 1.6 (1.5–1.8) |
| Upper limb | 19.8% (12.5–28.1) | 51.0% (40.6–60.4) | 29.2% (19.8–38.5) | 0.1 (0.1–0.2) | 0.3 (0.2–0.4) | 0.2 (0.1–0.2) |
| Trunk | 35.8% (25.4–46.3) | 40.3% (28.3–52.2) | 23.9% (13.4–34.3) | 0.2 (0.2–0.3) | 0.2 (0.2–0.3) | 0.1 (0.1–0.2) |
| Head/neck | 44.0% (24.0–64.0) | 40.0% (20.0–60.0) | 16.0% (4.0–32.0) | 0.1 (0.1–0.2) | 0.1 (0.1–0.2) | 0.1 (0.0–0.1) |
| Training injuries | 30.2% (26.0–34.6) | 50.4% (45.4–55.0) | 19.4% (15.7–23.3) | 1.1 (1.0–1.3) | 1.9 (1.7–2.1) | 0.7 (0.6–0.9) |
| Lower limb | 28.9% (24.1–33.7) | 52.4% (46.5–57.5) | 18.7% (15.0–22.9) | 0.9 (0.8–1.1) | 1.7 (1.5–1.9) | 0.6 (0.5–0.7) |
| Upper limb | 17.6% (0.0–35.3) | 58.8% (35.3–82.4) | 23.5% (5.9–41.2) | 0.04 (0.01–0.08) | 0.14 (0.09–0.20) | 0.06 (0.02–0.09) |
| Trunk | 46.4% (28.6–64.3) | 28.6% (10.7–46.4) | 25.0% (10.7–42.9) | 0.11 (0.06–0.16) | 0.07 (0.03–0.11) | 0.06 (0.02–0.10) |
| Head/neck | 55.6% (22.2–88.9) | 22.2% (0.0–55.6%) | 22.2% (0.0–55.6%) | 0.05 (0.02–0.08) | 0.02 (0.00–0.04) | 0.02 (0.00–0.04) |
| Match-injuries | 25.1% (21.7–28.7) | 51.1% (47.0–55.2) | 23.8% (20.3–27.0) | 12.5 (10.8–14.1) | 25.5 (23.1–27.8) | 11.9 (10.3–13.5) |
| Lower limb | 25.3% (21.2–29.2) | 51.5% (47.0–56.3) | 23.2% (19.3–26.8) | 9.8 (8.3–11.2) | 19.9 (17.8–22.0) | 9.0 (7.6–10.3) |
| Upper limb | 20.5% (1.5–29.5) | 48.7% (37.2–60.3) | 30.8% (20.5–41.0) | 1.5 (0.9–2.0) | 3.5 (2.6–4.3) | 2.2 (1.5–2.9) |
| Trunk | 25.0% (10.7–42.9) | 53.6% (35.7–71.4) | 21.4% (7.1–35.7) | 0.6 (0.3–1.0) | 1.3 (0.8–1.9) | 0.5 (0.2–0.8) |
| Head/neck | 37.5% (18.8–62.5) | 50.0% (25.0–75.0) | 12.5% (7.1–35.7) | 0.6 (0.3–1.0) | 0.8 (0.4–1.2) | 0.2 (0.0–0.4) |
Note:
Mild (1–7 days), moderate (8–28 days), severe (29+ days). Incidence reported per 1,000 exposure hours.
Time-loss and injury burden per activity.
| Mean time-loss days | Percentage of all time-loss | ||||||
|---|---|---|---|---|---|---|---|
| All injuries | Match-play | Training | All injuries | Match-play | Training | Injury burden MP: TR RR | |
| All regions | 25.7 (23.4–28.3) | 24.0 (21.6–26.6) | 22.8 (19.3–27.2) | – | 51.8% (51.2–52.1) | 39.5% (36.7–42.8) | 13.44 (12.34–14.87) |
| Lower limb | 25.4 (22.8–28.5) | 23.5 (21.1–26.4) | 22.6 (18.9–27.2) | 79.1% (77.9–80.6) | 76.1% (76.0–77.2) | 83.0% (82.0–83.7) | 12.58 (11.54–13.78) |
| Upper limb | 28.8 (22.5–36.4) | 29.9 (22.3–38.3) | 23.7 (16.8–31.3) | 11.2% (9.6–12.8) | 17.7% (14.6–20.4) | 6.6% (5.5–7.3) | 44.79 (38.49–54.50) |
| Trunk | 28.9 (18.6–42.6) | 22.4 (13.3–35.8) | 27.0 (13.4–45.2) | 7.4% (5.2–9.9) | 4.6% (3.0–6.6) | 8.9% (5.2–12.4) | 6.94 (6.34–8.44) |
| Head/neck | 13.3 (8.8–18.2) | 11.8 (7.8–17.4) | 16.0 (7.5–25.3) | 1.8% (1.3–2.2) | 1.5% (1.1–2.0) | 1.7% (0.9–2.3) | 11.80 (10.4–14.44) |
Note:
MP, Match-play; TR, training; RR, relative ratio.